LIGNOCAINE AS ANALGESIA IN BURN PATIENTS

EFFICACY OF INTRAVENOUS LIGNOCAINE AS ADJUVANT ANALGESIA IN BURN PATIENTS DURING CHANGE OF DRESSING UNDER GENERAL ANESTHESIA

Status

Active, not recruiting

Phases

Phase 2

Study type

Interventional

Source

IRCT

Registry ID

IRCT20230816059169N1

Enrollment

Registered

2023-09-11

Start date

2023-01-01

Completion date

Unknown

Last updated

2023-10-16

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Burns. Burn of unspecified body region, unspecified degree

Interventions

Intervention 1: Intervention group: Group L (Intravenous lignocaine) Patients in Group L received intravenous lignocaine at a dose of 1.5 mg/kg infused over 5 minutes before induction whereas patient

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: All ASA status patients presenting to the operating room for change of dressing under general anesthesia for full thickness burns

Exclusion criteria

Exclusion criteria: Patient with metastatic disease, post chemotherapy Major cardiac or respiratory disease Patients with partial thickness burns Those unwilling to be included in the study

Design outcomes

Primary

Measure	Time frame
Mean heart rate, blood pressure and oxygen saturation. Timepoint: Pre-induction, 5 min and 30 minutes into procedure. Method of measurement: Standard cardiac monitor.;Median pain scores on standardized Visual Analog Scale. Timepoint: 1-hour post-extubation in the recovery. Method of measurement: Standard Visual Analog Scale.	—

Countries

Pakistan

Contacts

Public ContactDr Muhammad Zaheer ud din

CMH Rawalpindi

xaheertiwana@gmail.com+92 333 4319191

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026